NEW PODCAST | Japan Characteristics in Healthcare Logistics – ANA Cargo & Nippon Express
Japan, a global leader in cutting-edge innovation, plays a significant role in the pharmaceutical market, with its pharmaceutical export industry set to exceed 54 billion US dollars by 2031. This podcast episode explores the role of international carriers like ANA Cargo and 3PL players such as Nippon Express in the Japanese life science market.
Join Frank Van Gelder, Secretary General of Pharma.Aero, and his guests, Masahiko Takahashi, Vice President Global Marketing of ANA Cargo, and Eddy Coopmans, Senior Healthcare Manager, Nippon Express Belgium, for a discussion revolving around the importance of air transport in the pharmaceutical industry, the challenges posed by evolving healthcare products like ATMP, and the necessity for global collaboration to enhance supply chain operations.
“Sea transportation is dominant in terms of weight, accounting for almost 80%, but in terms of value, air import and export account for over 86% of import and export in Japan.”
“The demand for CGT products is increasing in Japan, with the gene therapy market projected to increase 20 times larger in 15 years starting from 2020.”
“We have been strengthening our logistics contribution to the healthcare industry as a priority industry, focusing on medical devices and pharmaceuticals, and aiming for global expansion and organization development in the life science field.”
The direct air corridor between Belgium and Japan emerges as a crucial link, facilitating swift and secure transportation of healthcare products.
Pharma.Aero’s podcast, Insights, was launched in 2023 as a powerful platform to further showcase valuable expertise and insights on topics relevant to life science logistics. Since its first episode, the podcast delved deep into the complexities of the life sciences and med tech supply chain, presenting a unique opportunity to explore challenges, issues, and innovative ideas that shape the industry.
Tune in on Spotify where all episodes are available.